Poly(I:C) coated PLGA microparticles induce dendritic cell maturation

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Poly(D,L-lactic-co-glycolic acid) [PLGA] microparticles are increasingly used for antigen delivery in vaccines and cancer immunotherapy.
• A key challenge is inducing immune activation rather than tolerance, especially with weak antigens.
• Antigen-presenting cells (APCs), particularly dendritic cells (DCs), are crucial for initiating immune responses.

Purpose of the Study:

• To investigate the potential of protein-loaded PLGA microparticles to co-deliver maturation signals to human dendritic cells (DCs).
• To evaluate the efficacy of surface-coated Toll-like receptor (TLR) ligands on PLGA microparticles for DC maturation.

Main Methods:

• Modification of PLGA microparticles with diethylaminoethyl dextran.
• Surface coating of modified PLGA microparticles with polyinosine-polycytidylic acid [poly(I:C)], a TLR3 ligand.
• Incubation of modified microparticles with human DCs ex vivo.
• Assessment of DC phagocytosis and maturation.

Main Results:

• Poly(I:C) was successfully bound to the surface of modified PLGA microparticles in single or multilayer formats.
• These microparticles were effectively phagocytized by DCs.
• The surface-coated microparticles induced DC maturation comparable to cytokine cocktails or higher concentrations of soluble poly(I:C).

Conclusions:

• Surface coating biodegradable microparticles with TLR ligands is a viable strategy for enhancing DC maturation.
• This approach holds promise for DC-based cancer cell therapies and vaccination trials.
• It can specifically amplify immunological responses to encapsulated antigens.